Suppliers / AdhexPharma

AdhexPharma

France 169 employees Updated 9 July 2026

AdhexPharma is a contract manufacturer based in France. Its GMP standing is certified by ANSM (FR), EMA and US FDA. Its most recent recorded inspection, by US FDA, closed on 14 June 2023 as VAI.

0
active US DMFs
0
valid CEPs
3
registered plants 1 with an FDA FEI number
0
filings across 0 regulators
These figures were checked against the regulators' own files on 25 July 2026
Plants
1 of 1 confirmed
Inspections
2 of 2 confirmed
EU GMP
1 of 1 confirmed
Sources: FDA Establishment Registration, read 4 May 2026. FDA drug inspection classifications, read 4 May 2026. EudraGMDP (MIA + third-country GMP certs), read 4 May 2026.

Inspection history

  • 14 June 2023 VAI US FDA
  • 19 July 2019 VAI US FDA

NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.

Registered plants

Site FDA FEI
France, France 3008426496
21300 Additional Details: Adhexpharma - 42/44 rue de Longvic, France Not on file
Chenove, France Not on file

Filings and GMP by regulator

Regulator Filings GMP certificates
ANSM (FR) None 5
EMA None 1
US FDA None 1

Questions about AdhexPharma

Is AdhexPharma FDA-registered?
One site operated by AdhexPharma carries an FDA establishment identifier (FEI), which means it is registered with the FDA as a drug establishment. Registration is not the same as approval or inspection clearance.
How did AdhexPharma's last inspection go?
The most recent inspection on record closed on 14 June 2023 as VAI (Voluntary Action Indicated: issues were found but did not warrant regulatory action). 2 inspections are on file.
Where does AdhexPharma manufacture?
3 registered sites are on record, in France (France, 21300 Additional Details: Adhexpharma - 42/44 Rue De Longvic and Chenove). Every site is listed on this page with the register it came from.
Which regulators recognise AdhexPharma's GMP?
Current GMP certificates are on record from ANSM (FR), EMA and US FDA. GMP recognition covers the manufacturing site, separately from any filing on the substance itself.

Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.

Comparing suppliers?

Choose your molecules and target markets. AdhexPharma comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Open risk flags

  • The most recent inspection outcome was VAI, on 14 June 2023.

Comparable suppliers

Advanced Accelerator Applications also in France Aspen Notre Dame De Bondeville also in France Astrazeneca Dunkerque Production also in France Astrea Fontaine also in France Biocodex also in France

Ranked by shared active ingredients where we have them, otherwise by country and comparable credentials.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability
EudraGMDP and national regulators
GMP certificates